A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants
Part of paid clinical trials in Daytona Beach, Florida.
- Sponsor
- Genentech, Inc.
- Study ID
- NCT06677957
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Digoxin — DRUGDigoxin will be administered together with Rosuvastatin as a drug cocktail as specified for the respective period
- Divarasib — DRUGDivarasib will be administered in combination with Digoxin and Rosuvastatin as specified for the respective period
- Rosuvastatin — DRUGRosuvastatin will be administered together with Digoxin as a drug cocktail as specified for the respective period
Study Details
This is a Phase 1, open-label, two-period, one-sequence, crossover drug-drug interaction study to assess the P-gp and BCRP inhibition potential of divarasib using digoxin and rosuvastatin as probe substrates, respectively, in healthy participants.
Key Dates
- Start date
- Nov 6, 2024
- Status verified
- Jan 2025
- Primary completion
- Dec 30, 2024
- Completion
- Dec 30, 2024
Study Design
- Enrollment
- 19 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Treatment AParticipants will receive a single oral dose of Digoxin and Rosuvastatin drug cocktail.
- Experimental: Treatment BParticipants will receive a single dose of Digoxin and Rosuvastatin drug cocktail administered 2 hours after the Divarasib dose on Day 5.
Primary Outcome Measure
Maximum Observed Plasma Concentration (Cmax) of Digoxin and Rosuvastatin [ Time Frame: Day 1 of Period 1 and Day 5 of Period 2 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Daytona Beach Clinical Rsch Unit | Daytona Beach | Florida | 32117 | - |
Find similar trials in Daytona Beach, FL
By research site
Related Studies
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · Recruiting · Pfizer · Anaheim, California
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With DyslipidemiaPHASE1 · Recruiting · AstraZeneca · Glendale, California
- A Study to Learn About a Vaccine Against E Coli in Healthy AdultsPHASE1 · Recruiting · Pfizer · Anaheim, California
- The Increasing Mindfulness Engagement ProjectRecruiting · Florida State University · Tallahassee, Florida